
    
      The primary objective of the study is to assess the efficacy of unfractionated heparin sodium
      of porcine origin (Eurofarma) in the prophylaxis of VTE relative to unfractionated heparin
      sodium of porcine origin from APP Pharmaceuticals. The primary endpoint will be the frequency
      of DVT determined by Doppler ultrasound (DUS).
    
  